4.77
0.11 (2.36%)
0.11 (2.36%)
Upgrade to Real-Time
Afterhours (Closed)
Low
3.22
High
19.085
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gemini Therapeutics Inc | GMTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.11 | 2.36% | 4.77 | 18:41:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.66 | 4.585 | 4.80 | 4.77 | 4.66 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.78 | 4.85 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,726 | 793,095 | $ 4.70 | $ 3,724,486 | - | 3.22 - 19.085 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:11:34 | 76 | $ 4.77 | USD |
Period:
Draw Mode:
Gemini Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 205.63M | 43.11M | 22.15M | $ - | $ - | -0.38 | -4.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 0.30% |
Gemini Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GMTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.08 | 5.16 | 4.42 | 4.63 | 246,277 | -0.31 | -6.1% |
| 1 Month | 3.28 | 5.48 | 3.22 | 4.71 | 336,774 | 1.49 | 45.43% |
| 3 Months | 6.70 | 6.74 | 3.22 | 5.23 | 375,047 | -1.93 | -28.81% |
| 6 Months | 17.70 | 18.65 | 3.22 | 8.30 | 383,741 | -12.93 | -73.05% |
| 1 Year | 12.15 | 19.085 | 3.22 | 8.91 | 355,971 | -7.38 | -60.74% |
| 3 Years | 12.15 | 19.085 | 3.22 | 8.91 | 355,971 | -7.38 | -60.74% |
| 5 Years | 12.15 | 19.085 | 3.22 | 8.91 | 355,971 | -7.38 | -60.74% |
Gemini Therapeutics Description
| Gemini Therapeutics Inc is a clinical-stage precision medicine company developing novel therapeutic compounds to treat genetically defined AMD. Its candidate, GEM103, is a recombinant form of the Complement Factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health. |
